Evidence map›Paper›PMID 24724595›Full record

ReviewJournal of neuroendocrinology2014

Novel aspects of glucocorticoid actions.

E T Uchoa, G Aguilera, J P Herman, J L Fiedler, T Deak, M B C de Sousa

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neuroendocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 143 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Available Therapeutic Options for Corneal Neovascularization: A Review.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

E T UchoaDepartment of Physiology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao, Preto, SP, Brazil.
G Aguilera
J P Herman
J L Fiedler
T Deak
M B C de Sousa
Binghamton University · USNational Institutes of Health · USUniversidade de Ribeirão Preto · BRUniversidade Federal do Rio Grande do Norte · BRUniversity of Chile · CLUniversity of Cincinnati · US

Funding

FUNCTIONAL ANATOMY OF LIMBIC NEUROENDOCRINE CIRCUITSR01MH049698 · NIMH · UNIVERSITY OF KENTUCKY · PI HERMAN, JAMES P · 1998 to 2018
$6.2M
Neuroendocrine Control Of The Stress ResponseZIAHD000631 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI AGUILERA, GRETI · 2009 to 2014
$4.0M
Brainstem Mechanisms of Stress RegulationR01MH069860 · NIMH · UNIVERSITY OF CINCINNATI · PI HERMAN, JAMES P · 2004 to 2014
$3.5M
NEUROENDOCRINE CONTROL OF THE STRESS RESPONSEZ01HD000631 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI AGUILERA, GRETI · 1990 to 2008
$2.2M
FUNCTIONAL ANATOMY OF LIMBIC/NEUROENDOCRINE CIRCUITSR29MH049698 · NIMH · UNIVERSITY OF KENTUCKY · PI HERMAN, JAMES P · 1992 to 1996
–
Intramural NIH HHS Z01 HD000631NIMH NIH HHS MH049698NIMH NIH HHS MH069860NIMH NIH HHS R01 MH049698NIMH NIH HHS R01 MH069860
6 · The paper itself

Abstract

Normal hypothalamic-pituitary-adrenal (HPA) axis activity leading to the rhythmic and episodic release of adrenal glucocorticoids (GCs) is essential for body homeostasis and survival during stress. Acting through specific intracellular receptors in the brain and periphery, GCs regulate behaviour, as well as metabolic, cardiovascular, immune and neuroendocrine activities. By contrast to chronic elevated levels, circadian and acute stress-induced increases in GCs are necessary for hippocampal neuronal survival and memory acquisition and consolidation, as a result of the inhibition of apoptosis, the facilitation of glutamatergic neurotransmission and the formation of excitatory synapses, and the induction of immediate early genes and dendritic spine formation. In addition to metabolic actions leading to increased energy availability, GCs have profound effects on feeding behaviour, mainly via the modulation of orexigenic and anorixegenic neuropeptides. Evidence is also emerging that, in addition to the recognised immune suppressive actions of GCs by counteracting adrenergic pro-inflammatory actions, circadian elevations have priming effects in the immune system, potentiating acute defensive responses. In addition, negative-feedback by GCs involves multiple mechanisms leading to limited HPA axis activation and prevention of the deleterious effects of excessive GC production. Adequate GC secretion to meet body demands is tightly regulated by a complex neural circuitry controlling hypothalamic corticotrophin-releasing hormone (CRH) and vasopressin secretion, which are the main regulators of pituitary adrenocorticotrophic hormone (ACTH). Rapid feedback mechanisms, likely involving nongenomic actions of GCs, mediate the immediate inhibition of hypothalamic CRH and ACTH secretion, whereas intermediate and delayed mechanisms mediated by genomic actions involve the modulation of limbic circuitry and peripheral metabolic messengers. Consistent with their key adaptive roles, HPA axis components are evolutionarily conserved, being present in the earliest vertebrates. An understanding of these basic mechanisms may lead to novel approaches for the development of diagnostic and therapeutic tools for disorders related to stress and alterations of GC secretion.

Indexed as

AnimalsBrainEatingFeedback, PhysiologicalGlucocorticoidsHypothalamo-Hypophyseal SystemInflammation MediatorsModels, BiologicalNeuronal PlasticityNeurosecretory SystemsPituitary-Adrenal SystemReceptors, GlucocorticoidReceptors, MineralocorticoidStress, PhysiologicalGlucocorticoidsInflammation MediatorsReceptors, GlucocorticoidReceptors, Mineralocorticoidfeedbackfood intakeglucocorticoidsHPA axisimmune systemneuroplasticity

Identifiers

PMID24724595
PMCPMC4161987
OpenAlexW2045288044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.